IHE — iShares U.S. Pharmaceuticals ETF price, holdings and performance

iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF (AMEX: IHE) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.

Latest market price
103.03
+0.55+0.54%
OverviewShort InterestFilings
IHEiShares U.S. Pharmaceuticals ETF·AMEX
103.03+0.54%
TA
Loading chart...
Screen all →
VXUS-0.26%$86.98VUG-0.02%$89.39VTV+0.28%$224.94VO+0.07%$82.75VB-0.20%$305.48VGT-0.39%$120.98VWO-0.09%$60.41SPCK+1.54%$22.36
Fund Snapshot
Category-Asset TypeEquityTagshealthcareReturn% 1Y58.62%Total Holdings56Perf Week0.84%
SponsorISharesETF TypeTagssectorReturn% 3Y21.33%AUM$1.64BPerf Month0.24%
Fund FamilyBond TypeTags-Return% 5Y11.65%NAV/shPerf Quarter15.56%
Index-Average MaturityTags-Return% 10Y52W High105.59 -2.43%Perf Half Y16.05%
Index WeightingCommodity TypeTags-Return% SI52W Low65.29 57.79%Perf YTD20.79%
Active/PassiveQuant TypeTags-Flows% 1M46.08%Volatility1.93% 1.69%Perf Year53.47%
Dividend TTM1.47 (1.42%)ESG TypeTags-Flows% 3M57.05%ATR (14)1.84Perf 3Y69.71%
Dividend Ex-DateJun 15, 2026Dividend TypeSector/ThemeFlows% YTD79.45%RSI (14)58.31Perf 5Y60.33%
Dividend Gr. 3/5Y-Structure TypeRegionFlows% 1YBeta0.49Perf 10Y97.82%
Expense0.37%Growth/ValueSMA201.09%Flows% 3YRel Volume0.69Prev Close102.47
Inverse/LeveragedMarket CapSMA504.74%Flows% 5YAvg Volume220.55KPrice103.03
IPO DateMay 01, 2006Option/ShortYes / YesSMA20015.62%52W Range %94%Volume151,821Change0.54%
Assets Under Management
00.30B0.60B0.90B1.20B'24AprJunAugOct'25MarMayJulSepNov'26MarMayJul
● Assets Under Management
Latest News
Aug-07-26
Aug-07-2601:15AM
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocksbarrons.com
Jul-31-26
Jul-31-2611:53AM
XLV vs. IHE: Which Healthcare ETF Is the Better Buy?fool.com
Jul-30-26
Jul-30-2609:56AM
Will Generic Drug Tariffs Impact Pharma ETFs?zacks.com
04:35AM
Some More Notes On Pharmaceutical TariffsSeekingAlpha
12:28AM
Nikkei 225, Kospi jolt Asian markets as AI rout and Fed fears collideinvezz.com
Jul-24-26
Jul-24-2606:25AM
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?Benzinga
Jul-22-26
Jul-22-2604:33PM
Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?fool.com
12:32AM
Kospi jumps 6% as Asia's battered semiconductor trade reboundsinvezz.com
Jul-19-26
Jul-19-2606:27AM
IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now?fool.com
Jul-18-26
Jul-18-2608:16PM
IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors?fool.com
Jul-17-26
Jul-17-2608:50AM
The Next Big Theme: July 2026SeekingAlpha
Jul-16-26
Jul-16-2608:35AM
Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH?fool.com
Jul-15-26
Jul-15-2607:21AM
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?zacks.com
Jul-14-26
Jul-14-2610:56AM
Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surgezacks.com
Jul-10-26
Jul-10-2606:41AM
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?fool.com
Fund

The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR